Smith & Nephew plc (LON:SN) Given Consensus Rating of “Hold” by Brokerages

Smith & Nephew plc (LON:SN) has been assigned a consensus recommendation of “Hold” from the nine ratings firms that are covering the stock, MarketBeat reports. Six equities research analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average twelve-month price objective among brokers that have updated their coverage on the stock in the last year is GBX 1,310.

A number of research analysts have recently weighed in on SN shares. JPMorgan Chase & Co. cut their price objective on Smith & Nephew from GBX 1,438 to GBX 1,290 and set a “neutral” rating on the stock in a report on Thursday, August 6th. Citigroup lowered Smith & Nephew to a “buy” rating in a research report on Friday, July 10th. UBS Group reiterated a “neutral” rating and issued a GBX 1,300 price target on shares of Smith & Nephew in a report on Tuesday, May 5th. Berenberg Bank cut their price target on shares of Smith & Nephew from GBX 1,300 to GBX 1,250 and set a “hold” rating on the stock in a report on Friday, August 14th. Finally, Royal Bank Of Canada reduced their price target on shares of Smith & Nephew from GBX 1,350 to GBX 1,250 and set a “sector perform” rating for the company in a research report on Thursday, August 6th.

Smith & Nephew Trading Down 0.4%

LON SN opened at GBX 1,069.50 on Friday. The business has a 50-day moving average of GBX 1,129.08 and a two-hundred day moving average of GBX 1,183.24. The company has a current ratio of 2.14, a quick ratio of 0.84 and a debt-to-equity ratio of 73.07. The stock has a market capitalization of £11.72 billion, a PE ratio of 38.51, a P/E/G ratio of 0.46 and a beta of 0.69.

Smith & Nephew Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.